A detailed history of Arizona State Retirement System transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 19,431 shares of BEAM stock, worth $467,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,431
Previous 19,039 2.06%
Holding current value
$467,898
Previous $629,000 27.66%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$21.22 - $32.66 $8,318 - $12,802
392 Added 2.06%
19,431 $455,000
Q1 2024

May 07, 2024

BUY
$23.46 - $45.07 $5,161 - $9,915
220 Added 1.17%
19,039 $629,000
Q4 2023

Jan 24, 2024

BUY
$17.69 - $30.76 $6,598 - $11,473
373 Added 2.02%
18,819 $512,000
Q3 2023

Nov 06, 2023

BUY
$23.01 - $32.46 $50,115 - $70,697
2,178 Added 13.39%
18,446 $443,000
Q2 2023

Aug 01, 2023

SELL
$29.32 - $35.99 $1,964 - $2,411
-67 Reduced 0.41%
16,268 $519,000
Q1 2023

Apr 27, 2023

BUY
$30.15 - $48.79 $13,688 - $22,150
454 Added 2.86%
16,335 $500,000
Q4 2022

Feb 07, 2023

BUY
$36.73 - $51.6 $22,221 - $31,218
605 Added 3.96%
15,881 $621,000
Q3 2022

Nov 07, 2022

BUY
$39.79 - $70.31 $20,054 - $35,436
504 Added 3.41%
15,276 $728,000
Q2 2022

Jul 28, 2022

BUY
$29.86 - $62.36 $166,111 - $346,908
5,563 Added 60.41%
14,772 $572,000
Q1 2022

May 04, 2022

BUY
$53.73 - $82.16 $15,044 - $23,004
280 Added 3.14%
9,209 $528,000
Q4 2021

Feb 04, 2022

BUY
$68.02 - $99.06 $27,616 - $40,218
406 Added 4.76%
8,929 $712,000
Q3 2021

Nov 12, 2021

BUY
$84.37 - $133.6 $17,127 - $27,120
203 Added 2.44%
8,523 $742,000
Q2 2021

Aug 02, 2021

BUY
$64.12 - $128.71 $208,902 - $419,337
3,258 Added 64.36%
8,320 $1.07 Million
Q1 2021

May 06, 2021

BUY
$71.28 - $120.75 $10,264 - $17,388
144 Added 2.93%
5,062 $405,000
Q4 2020

Jan 28, 2021

BUY
$22.24 - $95.63 $109,376 - $470,308
4,918 New
4,918 $402,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.69B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.